Suppr超能文献

用于稳定mRNA和siRNA脂质纳米颗粒的固体剂型的干燥及开发的最新进展。

Recent advances in drying and development of solid formulations for stable mRNA and siRNA lipid nanoparticles.

作者信息

Arte Kinnari Santosh, Chen Manlin, Patil Chanakya D, Huang Yijing, Qu Li, Zhou Qi

机构信息

Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA.

Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA.

出版信息

J Pharm Sci. 2025 Feb;114(2):805-815. doi: 10.1016/j.xphs.2024.12.013. Epub 2024 Dec 16.

Abstract

Current RNA lipid nanoparticle (LNP) based products are typically liquid formulations that require ultra-cold storage temperatures for stability. To address this limitation, recent efforts have focused on enhancing stability and enabling room temperature storage by converting these formulations into solid forms through drying processes such as lyophilization, spray drying, and spray-freeze drying. Nevertheless, the drying process itself can influence the stability of RNA/LNP formulations. Therefore, understanding the factors that contribute to instability during drying is essential. The choice of drying technique for LNPs depends on factors such as the mode of delivery, lipid components, and desired final product characteristics. Additionally, the drying mechanism and associated stresses must also be carefully considered. Drying methods involve a range of process parameters related to formulation, process settings, and the manufacturing environment. It is essential to understand how these parameters influence the final solid-state products' attributes, including appearance, moisture content, flow properties, and reconstitution time, as these can significantly affect the physical and chemical stability of the formulation. This review focuses on various drying techniques and their impact on the stability of RNA/LNP-based systems.

摘要

目前基于RNA脂质纳米颗粒(LNP)的产品通常是液体制剂,需要超低温储存以保持稳定性。为了解决这一局限性,最近的努力集中在通过冻干、喷雾干燥和喷雾冷冻干燥等干燥过程将这些制剂转化为固体形式,从而提高稳定性并实现室温储存。然而,干燥过程本身会影响RNA/LNP制剂的稳定性。因此,了解干燥过程中导致不稳定的因素至关重要。LNP干燥技术的选择取决于给药方式、脂质成分和所需的最终产品特性等因素。此外,还必须仔细考虑干燥机制和相关应力。干燥方法涉及一系列与制剂、工艺设置和制造环境相关的工艺参数。了解这些参数如何影响最终固态产品的属性,包括外观、水分含量、流动特性和复溶时间,这一点至关重要,因为这些属性会显著影响制剂的物理和化学稳定性。本综述重点关注各种干燥技术及其对基于RNA/LNP系统稳定性的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验